333 related articles for article (PubMed ID: 28345455)
1. Recurrent epigenetic silencing of the PTPRD tumor suppressor in laryngeal squamous cell carcinoma.
Szaumkessel M; Wojciechowska S; Janiszewska J; Zemke N; Byzia E; Kiwerska K; Kostrzewska-Poczekaj M; Ustaszewski A; Jarmuz-Szymczak M; Grenman R; Wierzbicka M; Bartochowska A; Szyfter K; Giefing M
Tumour Biol; 2017 Mar; 39(3):1010428317691427. PubMed ID: 28345455
[TBL] [Abstract][Full Text] [Related]
2. High resolution ArrayCGH and expression profiling identifies PTPRD and PCDH17/PCH68 as tumor suppressor gene candidates in laryngeal squamous cell carcinoma.
Giefing M; Zemke N; Brauze D; Kostrzewska-Poczekaj M; Luczak M; Szaumkessel M; Pelinska K; Kiwerska K; Tönnies H; Grenman R; Figlerowicz M; Siebert R; Szyfter K; Jarmuz M
Genes Chromosomes Cancer; 2011 Mar; 50(3):154-66. PubMed ID: 21213369
[TBL] [Abstract][Full Text] [Related]
3. Recurrent transcriptional loss of the PCDH17 tumor suppressor in laryngeal squamous cell carcinoma is partially mediated by aberrant promoter DNA methylation.
Byzia E; Soloch N; Bodnar M; Szaumkessel M; Kiwerska K; Kostrzewska-Poczekaj M; Jarmuz-Szymczak M; Szylberg L; Wierzbicka M; Bartochowska A; Kalinowicz E; Grenman R; Szyfter K; Marszalek A; Giefing M
Mol Carcinog; 2018 Jul; 57(7):878-885. PubMed ID: 29566279
[TBL] [Abstract][Full Text] [Related]
4. Loss-of-Function PTPRD Mutations Lead to Increased STAT3 Activation and Sensitivity to STAT3 Inhibition in Head and Neck Cancer.
Peyser ND; Du Y; Li H; Lui V; Xiao X; Chan TA; Grandis JR
PLoS One; 2015; 10(8):e0135750. PubMed ID: 26267899
[TBL] [Abstract][Full Text] [Related]
5. PTPRD is homozygously deleted and epigenetically downregulated in human hepatocellular carcinomas.
Acun T; Demir K; Oztas E; Arango D; Yakicier MC
OMICS; 2015 Apr; 19(4):220-9. PubMed ID: 25831062
[TBL] [Abstract][Full Text] [Related]
6. Frequent promoter hypermethylation of PTPRT increases STAT3 activation and sensitivity to STAT3 inhibition in head and neck cancer.
Peyser ND; Freilino M; Wang L; Zeng Y; Li H; Johnson DE; Grandis JR
Oncogene; 2016 Mar; 35(9):1163-9. PubMed ID: 25982282
[TBL] [Abstract][Full Text] [Related]
7. The tyrosine phosphatase PTPRD is a tumor suppressor that is frequently inactivated and mutated in glioblastoma and other human cancers.
Veeriah S; Brennan C; Meng S; Singh B; Fagin JA; Solit DB; Paty PB; Rohle D; Vivanco I; Chmielecki J; Pao W; Ladanyi M; Gerald WL; Liau L; Cloughesy TC; Mischel PS; Sander C; Taylor B; Schultz N; Major J; Heguy A; Fang F; Mellinghoff IK; Chan TA
Proc Natl Acad Sci U S A; 2009 Jun; 106(23):9435-40. PubMed ID: 19478061
[TBL] [Abstract][Full Text] [Related]
8. Radioresistance in a human laryngeal squamous cell carcinoma cell line is associated with DNA methylation changes and topoisomerase II α.
Kim JS; Kim SY; Lee M; Kim SH; Kim SM; Kim EJ
Cancer Biol Ther; 2015; 16(4):558-66. PubMed ID: 25719218
[TBL] [Abstract][Full Text] [Related]
9. Frequent hypermethylation of WNT pathway genes in laryngeal squamous cell carcinomas.
Paluszczak J; Hemmerling D; Kostrzewska-Poczekaj M; Jarmuż-Szymczak M; Grenman R; Wierzbicka M; Baer-Dubowska W
J Oral Pathol Med; 2014 Oct; 43(9):652-7. PubMed ID: 24762262
[TBL] [Abstract][Full Text] [Related]
10. LMX1B mRNA expression and its gene body CpG methylation are valuable prognostic biomarkers for laryngeal squamous cell carcinoma.
Fan L; Zhang A; Deng P
Biomed Pharmacother; 2019 Sep; 117():109174. PubMed ID: 31387183
[TBL] [Abstract][Full Text] [Related]
11. Methylation-associated silencing of death-associated protein kinase gene in laryngeal squamous cell cancer.
Kong WJ; Zhang S; Guo C; Zhang S; Wang Y; Zhang D
Laryngoscope; 2005 Aug; 115(8):1395-401. PubMed ID: 16094112
[TBL] [Abstract][Full Text] [Related]
12. RAR beta2 suppression in head and neck squamous cell carcinoma correlates with site, histology and age.
Olasz J; Juhász A; Remenár E; Engi H; Bak M; Csuka O; Kásler M
Oncol Rep; 2007 Jul; 18(1):105-12. PubMed ID: 17549354
[TBL] [Abstract][Full Text] [Related]
13. Recurrent CDK1 overexpression in laryngeal squamous cell carcinoma.
Bednarek K; Kiwerska K; Szaumkessel M; Bodnar M; Kostrzewska-Poczekaj M; Marszalek A; Janiszewska J; Bartochowska A; Jackowska J; Wierzbicka M; Grenman R; Szyfter K; Giefing M; Jarmuz-Szymczak M
Tumour Biol; 2016 Aug; 37(8):11115-26. PubMed ID: 26912061
[TBL] [Abstract][Full Text] [Related]
14. SSTR2 promoter hypermethylation is associated with the risk and progression of laryngeal squamous cell carcinoma in males.
Shen Z; Chen X; Li Q; Zhou C; Li J; Ye H; Duan S
Diagn Pathol; 2016 Jan; 11():10. PubMed ID: 26796520
[TBL] [Abstract][Full Text] [Related]
15. Promoter Methylation-Regulated miR-145-5p Inhibits Laryngeal Squamous Cell Carcinoma Progression by Targeting FSCN1.
Gao W; Zhang C; Li W; Li H; Sang J; Zhao Q; Bo Y; Luo H; Zheng X; Lu Y; Shi Y; Yang D; Zhang R; Li Z; Cui J; Zhang Y; Niu M; Li J; Wu Z; Guo H; Xiang C; Wang J; Hou J; Zhang L; Thorne RF; Cui Y; Wu Y; Wen S; Wang B
Mol Ther; 2019 Feb; 27(2):365-379. PubMed ID: 30341010
[TBL] [Abstract][Full Text] [Related]
16. Promoter methylation of TIMP3 and CDH1 predicts better outcome in head and neck squamous cell carcinoma treated by radiotherapy only.
De Schutter H; Geeraerts H; Verbeken E; Nuyts S
Oncol Rep; 2009 Feb; 21(2):507-13. PubMed ID: 19148529
[TBL] [Abstract][Full Text] [Related]
17. Frequent gene hypermethylation in laryngeal cancer cell lines and the resistance to demethylation induction by plant polyphenols.
Paluszczak J; Krajka-Kuźniak V; Małecka Z; Jarmuż M; Kostrzewska-Poczekaj M; Grenman R; Baer-Dubowska W
Toxicol In Vitro; 2011 Feb; 25(1):213-21. PubMed ID: 21078381
[TBL] [Abstract][Full Text] [Related]
18. Metastatic cutaneous squamous cell carcinoma shows frequent deletion in the protein tyrosine phosphatase receptor Type D gene.
Lambert SR; Harwood CA; Purdie KJ; Gulati A; Matin RN; Romanowska M; Cerio R; Kelsell DP; Leigh IM; Proby CM
Int J Cancer; 2012 Aug; 131(3):E216-26. PubMed ID: 22052591
[TBL] [Abstract][Full Text] [Related]
19. Utility of MS-MLPA in DNA methylation profiling in primary laryngeal squamous cell carcinoma.
López F; Sampedro T; Llorente JL; Domínguez F; Hermsen M; Suárez C; Alvarez-Marcos C
Oral Oncol; 2014 Apr; 50(4):291-7. PubMed ID: 24444674
[TBL] [Abstract][Full Text] [Related]
20. Pyrosequencing-based DNA methylation profiling of Fanconi anemia/BRCA pathway genes in laryngeal squamous cell carcinoma.
Szaumkessel M; Richter J; Giefing M; Jarmuz M; Kiwerska K; Tönnies H; Grenman R; Heidemann S; Szyfter K; Siebert R
Int J Oncol; 2011 Aug; 39(2):505-14. PubMed ID: 21567085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]